Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
2000 1
2001 2
2002 6
2003 8
2004 4
2005 8
2006 5
2007 7
2008 12
2009 6
2010 8
2011 10
2012 13
2013 13
2014 18
2015 15
2016 17
2017 12
2018 18
2019 16
2020 15
2021 17
2022 20
2023 10
2024 17
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

247 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
Therapeutic issues in Guillain-Barré syndrome.
Magy L, Frachet S. Magy L, et al. Expert Rev Neurother. 2023 Jun;23(6):549-557. doi: 10.1080/14737175.2023.2212163. Epub 2023 May 9. Expert Rev Neurother. 2023. PMID: 37151048 Review.
[Muscle cramps].
Fayolle D, Théaudin M, Ochsner F, Echaniz-Laguna A, Magy L, Vicino A, Hübers A. Fayolle D, et al. Among authors: magy l. Rev Med Suisse. 2022 Apr 27;18(779):785-788. doi: 10.53738/REVMED.2022.18.779.785. Rev Med Suisse. 2022. PMID: 35481501 French.
CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell-targeted therapies.
Le Cann M, Bouhour F, Viala K, Simon L, Tard C, Rossi C, Morel G, Lagrange E, Magy L, Créange A, Michaud M, Franques J, Echaniz-Laguna A, Antoine JC, Baron M, Arnulf B, Puma A, Delmont E, Maisonobe T, Leblond V, Roos-Weil D. Le Cann M, et al. Among authors: magy l. Blood. 2020 Nov 19;136(21):2428-2436. doi: 10.1182/blood.2020007092. Blood. 2020. PMID: 32959046 Free article.
Endoneurial fibroblast-like cells.
Richard L, Topilko P, Magy L, Decouvelaere AV, Charnay P, Funalot B, Vallat JM. Richard L, et al. Among authors: magy l. J Neuropathol Exp Neurol. 2012 Nov;71(11):938-47. doi: 10.1097/NEN.0b013e318270a941. J Neuropathol Exp Neurol. 2012. PMID: 23095846 Review.
[Hashimoto's encephalitis].
Magy L, Vallat JM. Magy L, et al. Rev Neurol (Paris). 2002 Oct;158(10 Pt 1):966-70. Rev Neurol (Paris). 2002. PMID: 12407305 Review. French.
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS.
Jouvenot G, Courbon G, Lefort M, Rollot F, Casey R, Le Page E, Michel L, Edan G, de Seze J, Kremer L, Bigaut K, Vukusic S, Mathey G, Ciron J, Ruet A, Maillart E, Labauge P, Zephir H, Papeix C, Defer G, Lebrun-Frenay C, Moreau T, Laplaud DA, Berger E, Stankoff B, Clavelou P, Thouvenot E, Heinzlef O, Pelletier J, Al-Khedr A, Casez O, Bourre B, Cabre P, Wahab A, Magy L, Camdessanché JP, Doghri I, Moulin S, Ben-Nasr H, Labeyrie C, Hankiewicz K, Neau JP, Pottier C, Nifle C, Collongues N, Kerbrat A; OFSEP Investigators. Jouvenot G, et al. Among authors: magy l. JAMA Neurol. 2024 May 1;81(5):490-498. doi: 10.1001/jamaneurol.2024.0395. JAMA Neurol. 2024. PMID: 38526462
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT, Gwathmey KG, Hewamadduma C, Hofman E, Hussain YM, Kuwabara S, Le Masson G, Leypoldt F, Chang T, Lipowska M, Lowe M, Lauria G, Querol L, Simu MA, Suresh N, Tse A, Ulrichts P, Van Hoorick B, Yamasaki R, Lewis RA, van Doorn PA; ADHERE Study Group. Allen JA, et al. Lancet Neurol. 2024 Oct;23(10):1013-1024. doi: 10.1016/S1474-4422(24)00309-0. Lancet Neurol. 2024. PMID: 39304241 Clinical Trial.
[Peripheral neuropathies].
Frachet S, Magy L. Frachet S, et al. Among authors: magy l. Rev Prat. 2024 Feb;74(2):209-216. Rev Prat. 2024. PMID: 38415428 French. No abstract available.
[Small fiber neuropathy diagnosis].
Théaudin M, Ochsner F, Adam C, Echaniz-Laguna A, Magy L, Fayolle D, Vicino A, Hübers A, Pereon Y. Théaudin M, et al. Among authors: magy l. Rev Med Suisse. 2022 Apr 27;18(779):803-807. doi: 10.53738/REVMED.2022.18.779.803. Rev Med Suisse. 2022. PMID: 35481505 French.
247 results